Aclaris Therapeutics (ACRS) Asset Utilization Ratio (2017 - 2026)
Aclaris Therapeutics' (ACRS) Asset Utilization Ratio was 0.04 for Q2 2026, down 49.9% from 0.09 a year earlier and down 6.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Dating back to Q4 2017, Aclaris Therapeutics' Asset Utilization Ratio record includes 35 quarters.
- By year, Asset Utilization Ratio came in at 0.09 in FY2024 (-35.2%), 0.14 in FY2023 (+17.5%), 0.12 in FY2022 (+180.1%) and 0.04 in FY2021 (-45.2%).
- The Q2 2026 figure ranks as the lowest quarterly Asset Utilization Ratio since Q2 2022.
- Year over year, Asset Utilization Ratio has now declined in each of the last seven quarters, with an average decline of 33.2% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q2 2023 (growth of 450.2%); the low point was Q4 2021 (a decline of 71.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.05 (Q1 2026), 0.05 (Q4 2025) and 0.09 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.45 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.47 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | 0.03 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.03 |
| Jun 30, 2026 | 0.04 |
| Mar 31, 2026 | 0.05 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.16 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.09 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 0.11 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.03 |
API Access
Aclaris Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();